SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

RZLV is trending due to positive analyst ratings and excitement around the company's potential in the AI-powered retail space, particularly following the appointment of a former Microsoft executive. The community is actively discussing the possibility of a short squeeze and anticipating strong earnings on October 1st. Some investors are drawing comparisons to Palantir, expressing long-term bullish sentiment, while others are wary of a potential pullback.

TOSHI

TOSHI.X is trending due to recent listings on South Korean exchanges like Bithumb and Upbit, sparking excitement about increased accessibility and trading volume from the Korean market. The community is speculating on potential future listings on major exchanges like Binance and Robinhood, while also discussing a possible partnership with Coinbase One. Some traders are also debating entry and exit strategies amidst price fluctuations.

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.

Vyome Holdings Inc.

Vyome Holdings (HIND) is trending due to an upcoming merger vote, with the community anticipating a positive outcome and a ticker change to HIND. Bullish sentiment surrounds the potential for a low-float squeeze and long-term growth, driven by Vyome's pipeline. Some traders are discussing the potential for a post-merger run, drawing comparisons to other recently merged stocks.

FG Nexus, Inc. engages in the provision of reinsurance, asset management and merchant banking services. The company was founded in October 2012 and is headquartered in Charlotte, NC.

FG Nexus Inc.

Fundamental Global Inc.

Shares of FGNX are volatile amidst discussions around a massive share authorization and potential Ethereum strategy. The community is debating the implications of the approved share increase, with some anticipating significant dilution, while others speculate about the company's potential to become a major player in the Ethereum space via buybacks. High borrowing costs and locate costs are also fueling speculation of a potential short squeeze.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid discussions about its ad-supported tier, potential bidding wars with other media giants, and the upcoming Canelo fight viewership data. Community members are weighing the potential impact of these factors on the stock's future, with some focusing on chart patterns and technical analysis while others speculate about subscriber growth and market competition. The Loop Capital upgrade and news around Loop’s price target upgrade may also be influencing the stock's movement.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending as the community discusses a potential short squeeze, fueled by news of 'Pharma Bro' Martin Shkreli shorting the stock, prompting retail investors to rally against him. Bullish sentiment is further supported by a new CEO, expansion plans to cover the entire continental US, and anticipation surrounding upcoming interest rate decisions that could positively impact the housing market. The community is closely watching for a potential breakout and discussing various price targets.

Presidio Property Trust, Inc. is a self-managed real estate investment trust, which invests in a diverse multi-tenant portfolio of real estate assets. It operates through the following segments: Office and Industrial Properties, Model Home Properties, and Retail Properties. The Office and Industrial Properties segment consists of office buildings and an industrial property leased to a variety of tenants ranging from small businesses to large public companies. The Model Home Properties segment consists of model home residential properties leased to homebuilders. The Retail Properties segment includes shopping centers. The company was founded by Jack Kendrick Heilbron on September 28, 1999 and is headquartered in San Diego, CA.

Presidio Property Trust Inc - Ordinary Shares - Class A

SQFT is trending as a top gainer, attracting significant attention in pre-market trading, with community members pointing to its low float as a catalyst for potential massive spikes. Discussions highlight the stock's volatile movements and potential for both short-term gains and risks, with some traders taking profits while others anticipate further upside. The stock's behavior is also being compared to other high-flying tickers, with community members actively watching for breakout opportunities.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals (QNRX) is trending with high volume as traders discuss its "insane momentum" and potential for further gains, possibly to $20. Bullish sentiment seems to be driven by positive clinical data, specifically related to a pediatric peeling skin syndrome study, with some community members noting the stock's low float and potential for a short squeeze. However, some traders caution about potential pump-and-dump dynamics or dilution.

StableX Technologies, Inc. engages in the design, development, manufacture, and sale of compact electric fleet solutions for use within urban and short-haul markets. It offers the AYRO 311 and Club Car 411 models. The company was founded on May 19, 2016 and is headquartered in New York, NY.

StableX Technologies Inc.

StableX Technologies, Inc. 

SBLX is trending amid community discussions around pump and dumps, short squeezes, and comparisons to other volatile stocks like AYRO and QMMM. Some traders are optimistic about its low float and potential in the stablecoin industry, while others express concerns about potential rug pulls and dilution. Recent news regarding a stable coin purchase and a new leader appointment are also being discussed as potential catalysts.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending amid community excitement and discussions around potential government contracts, boosted by recent institutional buying and a congresswoman's disclosed position. The stock is viewed by some as undervalued compared to its peers, with community members actively debating its potential for a short squeeze and significant upside. Sentiment is fueled by AI and defense sector catalysts, with some comparing it to PLTR.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MIST take a look at $ATRA how they recovered from CRL in Jan and an offering in May. Very similar stories. And now we see 75% gain from 6$ lows to now around 10$. Both companies had CRL rejection due to third party not drug efficacy. 

Following this pattern I think we could definitely be at 2.50-3.00$ leading into December.

Jarry Jangles

Melvin Woods

Mario Hernandez

Scrooge McDuck

StockTwits for iOS

Milestone Pharmaceuticals Inc

Atara Biotherapeutics Inc

 how they recovered from CRL in Jan and an offering in May. Very similar stories. And now we see 75% gain from 6$ lows to now around 10$. Both companies had CRL rejection due to third party not drug efficacy. 

Following this pattern I think we could definitely be at 2.50-3.00$ leading into December.

@jjangles123

Between Apr 8 &amp; Jul 9, $MIST surged ~268% (0.65→2.40), crushing $ATRA’s ~65% (5.59→9.23) but still solid gain. 

But Milestone priced a ~$52.5M dilutive offering around the same time the FDA accepted its CRL response (July 11) . You surely can guess the market reaction!

StockTwits For Android 

’s ~65% (5.59→9.23) but still solid gain. 

But Milestone priced a ~$52.5M dilutive offering around the same time the FDA accepted its CRL response (July 11) . You surely can guess the market reaction!

Light Year

@VENIVICI I agree it wasnt great, went from 2.50 to 1.50. Ive only entered after the fact.

 I agree it wasnt great, went from 2.50 to 1.50. Ive only entered after the fact.

@jjangles123
This was certainly a great entry point. For the rest, they’ve pretty much reset the momentum and tempered investors’ enthusiasm.


This was certainly a great entry point. For the rest, they’ve pretty much reset the momentum and tempered investors’ enthusiasm.